OverviewChartNewsTraderScreen

RBI Knock-Out FACC/  AT0000A39W42  /

Stuttgart
8/8/2024  9:16:19 AM Chg.+0.004 Bid5:29:56 PM Ask5:29:56 PM Underlying Strike price Expiration date Option type
0.267EUR +1.52% -
Bid Size: -		 -
Ask Size: -		 FACC AG INH.AKT. 4.3983 - 12/31/2078 Call
GlobeNewswire 6/17 Kiniksa Pharmaceuticals Sponsors American Heart Association’s Addressing Recurrent Pericarditis Init...
GlobeNewswire 6/12 Milestone Pharmaceuticals to Host KOL Event for Investors “Learnings from the Field: Expert Perspect...
GlobeNewswire 6/10 Clinical ink Appoints Dr. Nicholas Alp, MD PhD FACC as Chief Medical Officer
GlobeNewswire 6/5 Daxor Corporation Appoints John L. Jefferies, M.D. as Chief Medical Officer
GlobeNewswire 6/4 Orchestra BioMed Announces Further Details on In-Person R&D Day in New York Featuring Key Opinion Le...
GlobeNewswire 5/17 Oragenics, Inc. to Host Webinar Panel on Neurotrauma Medicine
GlobeNewswire 5/17 Cytokinetics Hosts Muscle Biology-Focused Research Symposium: Contemporary Landscapes in Muscle Biol...
GlobeNewswire 5/16 CVRx Announces Key Senior Leadership Team Hires
GlobeNewswire 5/15 Study Shows High Volume Exercise Unrelated to Progression of Coronary Artery Calcium
GlobeNewswire 5/15 HeartFlow's Plaque Analysis Leading The Way: 95% Accuracy vs Invasive Imaging In Newly Published REV...
GlobeNewswire 5/7 Matinas BioPharma’s LNC Platform for the Delivery of Small Oligonucleotides Featured in Two Presenta...
GlobeNewswire 5/7 Rugby Provides Exploration Update on its Gold-Silver Projects in  Santa Cruz Province, Argentina
GlobeNewswire 5/2 Milestone® Pharmaceuticals Announces Data Presentations on Etripamil at Heart Rhythm 2024, 2024 Stan...
GlobeNewswire 4/30 Orchestra BioMed to Host In-Person R&D Day in New York on AVIM Therapy Program in Hypertensive Pacem...
GlobeNewswire 4/23 Clinical ink announces GlucoseReady™
GlobeNewswire 4/8 Milestone® Pharmaceuticals Announces Etripamil Data Demonstrating Patients’ Ability to Self-Manage R...
GlobeNewswire 4/7 Esperion Presents Important New Data from CLEAR Outcomes at ACC.24 Highlighting Value of NEXLETOL® (...
GlobeNewswire 4/1 Milestone® Pharmaceuticals to Present Data on Etripamil at the American College of Cardiology and Eu...
GlobeNewswire 3/27 Renexxion Ireland Ltd. and Dr. Falk Pharma GmbH Announce FDA Clearance of the Investigational New Dr...
GlobeNewswire 3/25 Esperion Announces Data from CLEAR Outcomes Sub-Groups as Poster Presentations, Moderated Session & ...
GlobeNewswire 3/25 Matinas BioPharma Announces Positive in vivo Safety Data with its Oral LNC-Docetaxel Formulation
GlobeNewswire 3/13 Wayne J. Franklin, M.D., F.A.C.C., named senior vice president of the Children’s National Heart Cent...
GlobeNewswire 3/12 HeartFlow Announces Publication of 10-year Follow-Up Data from the DISCOVER-FLOW Study in the Journa...
GlobeNewswire 2/27 Manuscript Discussing the Benefit of SeaStar Medical’s Selective Cytopheretic Device in Patients wit...
GlobeNewswire 2/26 HeartSciences Adds Key Advisor to its Scientific Advisory Board